Evolus, Inc. (EOLS) on GreekSoup https://greeksoup.ai/stocks/us/eols/ Every dated entry in the public record on Evolus, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Evolus, Inc.: short interest 6,408,688 shares at the 15 October 2026 settlement, 7.07 days to coverhttps://greeksoup.ai/stocks/us/eols/short-interest/us:EOLS:short-interest:2026-10-15:80aef64cb3Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolus, Inc.: short interest 5,628,168 shares at the 30 September 2026 settlement, 9.33 days to coverhttps://greeksoup.ai/stocks/us/eols/short-interest/us:EOLS:short-interest:2026-09-30:09bb167bedWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolus, Inc.: short interest 5,530,759 shares at the 15 September 2026 settlement, 6.60 days to coverhttps://greeksoup.ai/stocks/us/eols/short-interest/us:EOLS:short-interest:2026-09-15:445be08dfdTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolus, Inc.: Moatazedi David (See Remarks) sold 105,108 shares at $9.04 on 2 September 2026, $950,019https://greeksoup.ai/stocks/us/eols/insiders/us:EOLS:insider:2026-09-04:8e685ee123Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Evolus, Inc.: Form 144, DAVID MOATAZEDI plans to sell 105,108 shares worth $950,019 around 2 September 2026https://greeksoup.ai/stocks/us/eols/planned-sales/us:EOLS:planned-sale:2026-09-02:81f73d7712Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Evolus, Inc.: Schedule 13G filed by Soleus Capital Master Fund, L.P., 5.3% of the classhttps://greeksoup.ai/stocks/us/eols/holders/us:EOLS:schedule-13:2026-08-31:56b6a64a44Mon, 31 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Evolus, Inc.: short interest 5,368,957 shares at the 31 August 2026 settlement, 5.21 days to coverhttps://greeksoup.ai/stocks/us/eols/short-interest/us:EOLS:short-interest:2026-08-31:dfe16d361cMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolus, Inc.: short interest 5,853,655 shares at the 14 August 2026 settlement, 4.37 days to coverhttps://greeksoup.ai/stocks/us/eols/short-interest/us:EOLS:short-interest:2026-08-14:5213c06664Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Evolus, Inc. Q2 FY2026 results: revenue $84 million, net income -$8 millionhttps://greeksoup.ai/stocks/us/eols/results/fy2026-q2/us:EOLS:result:2026-08-05:ab9cdefc95Wed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Evolus, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/eols/filings/us:EOLS:filing:2026-08-05:5689ca89f6Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Evolus, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/eols/filings/us:EOLS:filing:2026-08-05:0ed4ba8c29Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Evolus, Inc. filed 8-K: material agreement, regulation fd disclosurehttps://greeksoup.ai/stocks/us/eols/filings/us:EOLS:filing:2026-08-04:cafc5433d3Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>